Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Dr. Reddy's Laboratories Ltd.
₹0
Invest in DRREDDY with up to 4.00x margin.
Trade with MTF₹0.00
₹0.00
₹1020.00
₹1379.70
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 4,282.70 | 4,618.60 | 7,809.50 | 5,562.90 | 5,015 |
| Operating Expense | 4,183.10 | 4,138.30 | 3,972.50 | 4,016.30 | 3,822.60 |
| Operating Profit | 99.60 | 480.30 | 3,837 | 1,443 | 1,192.40 |
| Depreciation | 314.30 | 294.80 | 279.80 | 264.50 | 265.10 |
| Interest | 41.40 | 33.40 | 19.20 | 31.10 | 43.30 |
| Tax | 13.60 | 129 | 975.10 | 361.10 | 270 |
| Net Profit | 90.60 | 387.30 | 2,961.20 | 1,200.70 | 849.40 |
₹1286.20
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 |
| FII | 27.5 | 26.8 | 25.8 | 25.3 | 24.7 | 22.3 |
| DII | 35.7 | 36.2 | 37.1 | 37.8 | 38.8 | 41.3 |
| Public | 10 | 10.2 | 10.2 | 10 | 9.6 | 9.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 9.7 L | 16.29 L | 59.56% |
| Week | 15.1 L | 22.87 L | 66.02% |
| 1 Month | 10.98 L | 18.8 L | 58.42% |
| 6 Month | 11.25 L | 18.73 L | 60.09% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Strong Momentum: Price above short, medium and long term moving averages
Upcoming results with Rising Delivery Volumes
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 10 Jul, 2025 | 8 | FINAL | 10 Jul, 2025 | Equity Share |
| 16 Jul, 2024 | 40 | FINAL | Equity Share | |
| 11 Jul, 2023 | 40 | FINAL | Equity Share | |
| 11 Jul, 2022 | 30 | FINAL | Equity Share | |
| 09 Jul, 2021 | 25 | FINAL | Equity Share | |
| 13 Jul, 2020 | 25 | FINAL | Equity Share | |
| 15 Jul, 2019 | 20 | FINAL | Equity Share | |
| 16 Jul, 2018 | 20 | FINAL | Equity Share | |
| 17 Jul, 2017 | 20 | FINAL | Equity Share | |
| 18 Jul, 2016 | 20 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹676 | ₹973.50 | ₹1,659 | ₹2,044 | ₹1,707 | ₹1,008 |
| % Change | 4.67% | -3.84% | 4.12% | 0.99% | -0.20% | -1.51% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 79.00 | 64.40 | 34.70 | 47.30 | 33.30 | 64.60 |
| 1 Year Return | 19.55 | 37.81 | 58.31 | -15.18 | 4.68 | 64.09 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5271.50
-3.02%
Biocon Ltd.
₹ 371.20
-2.23%
Divi's Laboratories Ltd.
₹ 6045.00
+0.51%
Ajanta Pharma Ltd.
₹ 2806.00
-2.57%
Zydus Lifesciences Ltd.
₹ 896.20
-0.83%
Glenmark Pharmaceuticals Ltd.
₹ 2169.50
+0.05%
Aurobindo Pharma Ltd.
₹ 1317.70
+0.76%
Sun Pharmaceutical Industries Ltd.
₹ 1794.60
-0.04%
Ipca Laboratories Ltd.
₹ 1594.50
+1.56%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2063.50
-1.05%
AstraZeneca Pharma India Ltd.
₹ 7860.00
-6.60%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2276.00
-1.96%
Pfizer Ltd.
₹ 4700.00
-0.20%
Abbott India Ltd.
₹ 26205.00
-0.76%
Torrent Pharmaceuticals Ltd.
₹ 4266.10
-0.73%
Lupin Ltd.
₹ 2333.80
-0.59%
Cipla Ltd.
₹ 1242.00
-0.19%
By signing up I certify terms, conditions & privacy policy